Overview
Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of reviews and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of pediatric conditions; and the practical management of specific clinical situations.
As a hybrid journal, Pediatric Drugs does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).
The Journal also offers a range of additional features designed to increase the visibility, readership, and educational value of the Journal content (more information).
- Editor
-
- Rod McNab
- Impact factor
- 3.7 (2022)
- 5 year impact factor
- 3.4 (2022)
- Submission to first decision (median)
- 7 days
- Downloads
- 308,124 (2023)
Latest articles
Journal updates
-
Pediatric Drugs Top Ten
The most popular contemporary papers in Pediatric Drugs for 2022.
-
Digital Features
Pediatric Drugs is able to host a range of digital features, with a number of options available to authors.
Journal information
- Electronic ISSN
- 1179-2019
- Print ISSN
- 1174-5878
- Abstracted and indexed in
-
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO
- EMBASE
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Portico
- ProQuest
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information